Defining the optimal selenium dose for prostate cancer risk reduction: insights from the u-shaped relationship between selenium status, DNA damage, and apoptosis
Chiang, Emily C ; Shen, Shuren ; Kengeri, Seema S ; Xu, Huiping ; Combs, Gerald F. Jr ; Morris, J. Steven ; Bostwick, David G ; Waters, David J
Randomized Phase II Trial of theMatrixMetalloproteinase Inhibitor BMS-275291in Hormone-Refractory Prostate Cancer Patients with Bone Metastases resource
Lara, P.N. Jr ; Stadler, W.M ; Longmate, J ; Quinn, D.I ; Wexler, J ; Van Loan, M ; Twardowski, P ; Gumerlock, P.H ; Vogelzang, N.J ; Vokes, E.E
Clinical cancer research, 2006, Vol.12, p.1556-1563
Noninvasive prediction of prostatic DNA damage by oxidative stress challenge of peripheral blood lymphocytes
Waters, David J ; Shen, Shuren ; Xu, Huiping ; Kengeri, Seema S ; Cooley, Dawn M ; Chiang, Emily C ; Chen, Yu ; Schlittler, Deborah ; Oteham, Carol ; Combs, Gerald F. Jr ; Glickman, Lawrence T ; Morris, J. Steven ; Bostwick, David G
Cancer epidemiology, biomarkers & prevention, 2007, Vol.16 (9), p.1906-1910